Clinical Trial Update: Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on V81444 assesses safety, tolerability, pharmacokinetics and preliminary efficacy in adults with ADHD across Phase 1 and Phase 2 studies.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• V81444

Snippet

Sponsor: Vernalis (R&D) Ltd | Conditions: ADHD | Phase 1, Phase 2 | Status: COMPLETED